Nodule detection algorithm based on multislice CT images for lung cancer screening

Author(s):  
Shinsuke Saita ◽  
Tomokazu Oda ◽  
Mitsuru Kubo ◽  
Yoshiki Kawata ◽  
Noboru Niki ◽  
...  
2002 ◽  
Author(s):  
Tomokazu Oda ◽  
Mitsuru Kubo ◽  
Yoshiki Kawata ◽  
Noboru Niki ◽  
Kenji Eguchi ◽  
...  

2018 ◽  
Vol 41 (3) ◽  
pp. 600-608
Author(s):  
Marcia E Clark ◽  
Ben Young ◽  
Laura E Bedford ◽  
Roshan das Nair ◽  
John F R Robertson ◽  
...  

Abstract Background Lung cancer screening can reduce lung cancer mortality by 20%. Screen-detected abnormalities may provide teachable moments for smoking cessation. This study assesses impact of pulmonary nodule detection on smoking behaviours within the first UK trial of a novel auto-antibody test, followed by chest x-ray and serial CT scanning for early detection of lung cancer (Early Cancer Detection Test–Lung Cancer Scotland Study). Methods Test-positive participants completed questionnaires on smoking behaviours at baseline, 1, 3 and 6 months. Logistic regression compared outcomes between nodule (n = 95) and normal CT groups (n = 174) at 3 and 6 months follow-up. Results No significant differences were found between the nodule and normal CT groups for any smoking behaviours and odds ratios comparing the nodule and normal CT groups did not vary significantly between 3 and 6 months. There was some evidence the nodule group were more likely to report significant others wanted them to stop smoking than the normal CT group (OR across 3- and 6-month time points: 3.04, 95% CI: 0.95, 9.73; P = 0.06). Conclusion Pulmonary nodule detection during lung cancer screening has little impact on smoking behaviours. Further work should explore whether lung cancer screening can impact on perceived social pressure and promote smoking cessation.


2000 ◽  
Vol 24 (2) ◽  
pp. 242-246 ◽  
Author(s):  
Shingo Iwano ◽  
Naoki Makino ◽  
Mitsuru Ikeda ◽  
Shigeki Itoh ◽  
Shunichi Ishihara ◽  
...  

2003 ◽  
Author(s):  
Mitsuru Kubo ◽  
Nobuhiro Yamada ◽  
Yoshiki Kawata ◽  
Noboru Niki ◽  
Kenji Eguchi ◽  
...  

2012 ◽  
Vol 85 (1017) ◽  
pp. e603-e608 ◽  
Author(s):  
R Kakinuma ◽  
K Ashizawa ◽  
T Kobayashi ◽  
A Fukushima ◽  
H Hayashi ◽  
...  

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 7562-7562
Author(s):  
Pechin Lo ◽  
Matthew S. Brown ◽  
Jonathan Goldin ◽  
Eran Barnoy ◽  
Hyun J. Kim ◽  
...  

7562 Background: The National Lung Screening Trial (NLST) recently demonstrated that lung cancer screening with low-dose CT reduces mortality. Current protocols use 4–8 mm nodules as positive screens. While there are some computer-aided nodule detection (CAD) systems currently available, they are rarely used in clinical practice because they generate too many false positives and lack reliable measurement tools. The purpose of this work is to develop a new CAD system to overcome these limitations and evaluate it against an expert panel of radiologists. Methods: The CAD system developed for lung nodule detection and measurement incorporates computer vision techniques including intensity thresholding, Euclidean Distance Transformation, and watershed segmentation. Rules pertaining to volume and shape were applied to automatically discriminate between nodules and bronchovascular anatomy. CAD system performance was assessed using 108 consecutive cases from the publically available Lung Imaging Database Consortium (LIDC), in which four radiologists reviewed each case. CT slice thickness ranged from 0.6–3.0 mm. Nodules were included that were: (a) ≥ 4mm, and (b) marked by a majority of the LIDC readers, and (c) ≥ 4 x CT slice thickness (to ensure adequate spatial resolution). Results: 44 of 108 subjects had one or more nodules meeting criteria. Median CAD sensitivity per subject for these 44 cases is reported for all nodules ≥ 4mm and the subset of nodules ≥ 8mm. The false positive (FP) rate per subject is reported for all 108 cases. The overall concordance correlation coefficient (CCC) between the CAD volume of each nodule and the LIDC reference volume was measured. Conclusions: Based on clinical CT screening protocols, a CAD system has been developed with high nodule sensitivity and a much lower false positive rate than previously reported systems. Automated volume measurements show strong agreement with the reference standard, providing a comprehensive detection and assessment workflow for lung cancer screening. [Table: see text]


Sign in / Sign up

Export Citation Format

Share Document